DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Moreno C, Greil R, Demirkan F. et al.
Ibrutinib + Obinutuzumab Versus Chlorambucil + Obinutuzumab As First-Line Treatment in Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL): Results from Phase 3 iLLUMINATE.

Blood 2018;
132: 691

Download Bibliographical Data

Search in: